United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2156_959dab21-96f5-44a0-a405-0343eeb428b5
- Product NDC
- 71335-2156
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080926
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (71335-2156-0) · 71335-2156-0
- 30 TABLET, FILM COATED in 1 BOTTLE (71335-2156-1) · 71335-2156-1
- 90 TABLET, FILM COATED in 1 BOTTLE (71335-2156-2) · 71335-2156-2
- 21 TABLET, FILM COATED in 1 BOTTLE (71335-2156-3) · 71335-2156-3
- 10 TABLET, FILM COATED in 1 BOTTLE (71335-2156-4) · 71335-2156-4
- 15 TABLET, FILM COATED in 1 BOTTLE (71335-2156-5) · 71335-2156-5
- 40 TABLET, FILM COATED in 1 BOTTLE (71335-2156-6) · 71335-2156-6
- 60 TABLET, FILM COATED in 1 BOTTLE (71335-2156-7) · 71335-2156-7
- 20 TABLET, FILM COATED in 1 BOTTLE (71335-2156-8) · 71335-2156-8
- 120 TABLET, FILM COATED in 1 BOTTLE (71335-2156-9) · 71335-2156-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →